Novo Still Owes $3M Over Patent Use Code Row, Caraco Says
Generic-drug maker Caraco Pharmaceutical Laboratories Ltd. on Wednesday brought a contract suit against Novo Nordisk A/S in Michigan federal court, saying Novo hasn't made good on the $2.75 million it owes...To view the full article, register now.
Already a subscriber? Click here to view full article